Are the long-term adverse events from #ocriplasmin exceeding the risks associated with a vitrectomy? Especially if all four studies were sponsored by the manufacturers of ocriplasmin and up to 20% of patients need further treatment. There's a 90+% success
67 followers
535 followers
RT @joaquinfdezoft: Admiration for the determined Commitment of @RCOphth (Royal College Ophthalmologist) to #EvidenceBasedMedicine with its…
472 followers
RT @CochraneEyes: #Cochrane Corner in Eye: #Ocriplasmin—why isn’t it being used more? https://t.co/pIaQ8v7syP @SunderlandEye @RCOphth @Moor…
140 followers
RT @joaquinfdezoft: Admiración por la decidida apuesta del @RCOphth (Royal College Ophthalmologist) por la #MedicinaBasadaEvidencia con su…